Posted by: DrugsNews on: 30 Nov, 2009
Reinvent Retirement
By Marc Freedman, Ode Magazine
Picture this: A fit, handsome sixty-something couple stretches out on a sandy beach. Another silver-haired pair steers a sailboat toward the sunset. A grey-templed golfer watches his drive soar down the fairway. This life of relaxation and luxury, in which every day is one big happy holiday, has long been [...]
Posted by: DrugsNews on: 30 Nov, 2009
Early Intervention Very Effective For Toddlers With Autism, Small Study
A small US study involving toddlers diagnosed with autism, some as as young as 18 months old, showed that intensive early intervention delivered by trained specialists and parents was very effective and improved IQ, social interaction and language ability.
Read more about Early [...]
Posted by: DrugsNews on: 30 Nov, 2009
Unusual Scrotal Pathology: An Overview
UroToday.com – The diverse embryological origins of the scrotal contents, including the genital swelling, the retroperitoneum, and the abdominal wall, create an environment where unusual pathologies can and do appear.
Read more about Unusual Scrotal Pathology: An Overview
Posted by: DrugsNews on: 30 Nov, 2009
Laparoscopic Partial Nephrectomy: Predictors Of Prolonged Warm Ischemia
UroToday.com – The best management of patients with small renal masses is the nephron sparing approach. This has been well shown to improve patients’ long-term renal function while providing equivalent oncologic management of their disease compared to open radical surgery.
Read more about Laparoscopic Partial Nephrectomy: Predictors Of [...]
Posted by: DrugsNews on: 30 Nov, 2009
Pattern Of Family History In Stone Patients
UroToday.com – The real aetiology of stone formation is still unclear to the common clinician. Researchers are groping in the dark trying to recognise the reversible and irreversible risk for future stone formation in an individual. Positive family history has been implicated as a main factor in the aetiology.
Read [...]
Posted by: DrugsNews on: 30 Nov, 2009
The Effect Of On-Line Position Correction On The Dose Distribution In Focal Radiotherapy For Bladder Cancer
UroToday.com – Radiotherapy, given in 20-25 fractions over 4-5 weeks, is usually the second choice for the treatment of muscle-invasive bladder cancer, behind radical cystectomy. Only patients unfit or unwilling to undergo surgery are referred for radiotherapy. An advantage of [...]
Posted by: DrugsNews on: 30 Nov, 2009
Tumor Perfusion Assessed By Dynamic Contrast-Enhanced MRI (DCE MRI) Correlates To The Grading Of Renal Cell Carcinoma
UroToday.com – The purpose of the clinical study was to evaluate whether quantitative parameters of tumor vascularisation assessed by DCE-MRI enable the determination of the morphologic grading of renal cell carcinomas non-invasively. Our prospective study included 21 patients suspected [...]
Posted by: DrugsNews on: 30 Nov, 2009
Urodynamic Effects Of Silodosin, A New Alpha(1A)-Adrenoceptor Selective Antagonist, For The Treatment Of Benign Prostatic Hyperplasia
UroToday.com – Silodosin is a newly developed α1A-adrenoceptor(AR) selective antagonist. It has been reported that blockade of α1A-AR was effective in the relief of bladder outlet obstruction, while the blockade of the α1D-AR was believed to alleviate storage symptoms due [...]
Posted by: DrugsNews on: 30 Nov, 2009
Can Residents Perform Transrectal Ultrasound-Guided Prostate Biopsy With Patient Comfort Comparable To Biopsy Performed By Attending Staff Urologists?
UroToday.com – Urology residents are involved with performing transrectal-ultrasound (TRUS) guided prostate biopsies during their training. Satisfactory accomplishment of this skill is a competency necessary for urologic practice.
Read more about Can Residents Perform Transrectal Ultrasound-Guided Prostate Biopsy [...]
Posted by: DrugsNews on: 30 Nov, 2009
Accord Set on Rights to Generic TriCor – Wall Street Journal
Accord Set on Rights to Generic TriCorWall Street JournalAbbott Laboratories and Laboratories Fournier SA have agreed to grant generic-drug maker Teva Pharmaceuticals Industries …
and more »
Read more about Accord Set on Rights to Generic TriCor – Wall Street Journal